Literature DB >> 20505331

Tumor suppression by the histone demethylase UTX.

Miao-Chih Tsai, Jordon K Wang, Howard Y Chang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20505331      PMCID： PMC3311649          DOI： 10.4161/cc.9.11.11845

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  11 in total

1.  The polycomb group protein EZH2 is involved in progression of prostate cancer.

Authors:  Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

2.  The histone demethylase UTX enables RB-dependent cell fate control.

Authors:  Jordon K Wang; Miao-Chih Tsai; Gino Poulin; Adam S Adler; Shuzhen Chen; Helen Liu; Yang Shi; Howard Y Chang
Journal:  Genes Dev       Date:  2010-02-01       Impact factor: 11.361

3.  Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination.

Authors:  Min Gyu Lee; Raffaella Villa; Patrick Trojer; Jessica Norman; Kai-Ping Yan; Danny Reinberg; Luciano Di Croce; Ramin Shiekhattar
Journal:  Science       Date:  2007-08-30       Impact factor: 47.728

4.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.

Authors:  Celina G Kleer; Qi Cao; Sooryanarayana Varambally; Ronglai Shen; Ichiro Ota; Scott A Tomlins; Debashis Ghosh; Richard G A B Sewalt; Arie P Otte; Daniel F Hayes; Michael S Sabel; Donna Livant; Stephen J Weiss; Mark A Rubin; Arul M Chinnaiyan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

5.  The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence.

Authors:  Karl Agger; Paul A C Cloos; Lise Rudkjaer; Kristine Williams; Gitte Andersen; Jesper Christensen; Kristian Helin
Journal:  Genes Dev       Date:  2009-05-15       Impact factor: 11.361

6.  Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS.

Authors:  Marta Barradas; Emma Anderton; Juan Carlos Acosta; Side Li; Ana Banito; Marc Rodriguez-Niedenführ; Goedele Maertens; Michaela Banck; Ming-Ming Zhou; Martin J Walsh; Gordon Peters; Jesús Gil
Journal:  Genes Dev       Date:  2009-05-15       Impact factor: 11.361

7.  Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.

Authors:  Yutaka Kondo; Lanlan Shen; Alfred S Cheng; Saira Ahmed; Yanis Boumber; Chantale Charo; Tadanori Yamochi; Takeshi Urano; Koichi Furukawa; Bernard Kwabi-Addo; David L Gold; Yoshitaka Sekido; Tim Hui-Ming Huang; Jean-Pierre J Issa
Journal:  Nat Genet       Date:  2008-05-18       Impact factor: 38.330

8.  EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.

Authors:  Adrian P Bracken; Diego Pasini; Maria Capra; Elena Prosperini; Elena Colli; Kristian Helin
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

9.  Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.

Authors:  Ryan D Morin; Nathalie A Johnson; Tesa M Severson; Andrew J Mungall; Jianghong An; Rodrigo Goya; Jessica E Paul; Merrill Boyle; Bruce W Woolcock; Florian Kuchenbauer; Damian Yap; R Keith Humphries; Obi L Griffith; Sohrab Shah; Henry Zhu; Michelle Kimbara; Pavel Shashkin; Jean F Charlot; Marianna Tcherpakov; Richard Corbett; Angela Tam; Richard Varhol; Duane Smailus; Michelle Moksa; Yongjun Zhao; Allen Delaney; Hong Qian; Inanc Birol; Jacqueline Schein; Richard Moore; Robert Holt; Doug E Horsman; Joseph M Connors; Steven Jones; Samuel Aparicio; Martin Hirst; Randy D Gascoyne; Marco A Marra
Journal:  Nat Genet       Date:  2010-01-17       Impact factor: 38.330

10.  Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes.

Authors:  Gillian L Dalgliesh; Kyle Furge; Chris Greenman; Lina Chen; Graham Bignell; Adam Butler; Helen Davies; Sarah Edkins; Claire Hardy; Calli Latimer; Jon Teague; Jenny Andrews; Syd Barthorpe; Dave Beare; Gemma Buck; Peter J Campbell; Simon Forbes; Mingming Jia; David Jones; Henry Knott; Chai Yin Kok; King Wai Lau; Catherine Leroy; Meng-Lay Lin; David J McBride; Mark Maddison; Simon Maguire; Kirsten McLay; Andrew Menzies; Tatiana Mironenko; Lee Mulderrig; Laura Mudie; Sarah O'Meara; Erin Pleasance; Arjunan Rajasingham; Rebecca Shepherd; Raffaella Smith; Lucy Stebbings; Philip Stephens; Gurpreet Tang; Patrick S Tarpey; Kelly Turrell; Karl J Dykema; Sok Kean Khoo; David Petillo; Bill Wondergem; John Anema; Richard J Kahnoski; Bin Tean Teh; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2010-01-06       Impact factor: 49.962
View more
  7 in total

Review 1.  The role of histone demethylases in cancer therapy.

Authors:  Inga Hoffmann; Martin Roatsch; Martin L Schmitt; Luca Carlino; Martin Pippel; Wolfgang Sippl; Manfred Jung
Journal:  Mol Oncol       Date:  2012-08-07       Impact factor: 6.603

2.  Spatial Organization of Epigenomes.

Authors:  Jonathan Christopher Dubé; Xue Qing David Wang; Josée Dostie
Journal:  Curr Mol Biol Rep       Date:  2016-02-04

Review 3.  Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

Authors:  Xuejiao Tian; Saiyang Zhang; Hong-Min Liu; Yan-Bing Zhang; Christopher A Blair; Dan Mercola; Paolo Sassone-Corsi; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

Review 4.  Histone Modifications and Cancer.

Authors:  James E Audia; Robert M Campbell
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-04-01       Impact factor: 10.005

5.  Expression and significance of histone H3K27 demethylases in renal cell carcinoma.

Authors:  Yongqing Shen; Xiaoqiang Guo; Yuejia Wang; Wei Qiu; Yanzhong Chang; Aili Zhang; Xianglin Duan
Journal:  BMC Cancer       Date:  2012-10-12       Impact factor: 4.430

6.  Kdm6a deficiency restricted to mouse hematopoietic cells causes an age- and sex-dependent myelodysplastic syndrome-like phenotype.

Authors:  Ling Tian; Monique Chavez; Gue Su Chang; Nichole M Helton; Casey D S Katerndahl; Christopher A Miller; Lukas D Wartman
Journal:  PLoS One       Date:  2021-11-15       Impact factor: 3.752

7.  Epigenetic control and cancer: the potential of histone demethylases as therapeutic targets.

Authors:  Fernando Lizcano; Jeison Garcia
Journal:  Pharmaceuticals (Basel)       Date:  2012-09-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.